Baseline Characteristics Module
The Baseline Characteristics Module provides demographic and baseline characteristics information for participants in a clinical trial. This module includes data such as population descriptions and the types of units analyzed, helping researchers understand the baseline characteristics of study participants.
Baseline Characteristics Module path is as follows:
Study -> Results Section -> Baseline Characteristics Module
Baseline Characteristics Module
Ignite Creation Date:
2025-12-24 @ 11:50 PM
Ignite Modification Date:
2025-12-25 @ 9:45 PM
NCT ID:
NCT04998851
Population Description:
Safety Analysis Set Mothers (SAFM) included all mothers who met the eligibility criteria and received any post-partum dose of ocrelizumab. Safety Analysis Set Infants (SAFI) included all the infants of women in the Full Analysis Set Mothers (FASM) population. As consent for race and ethnicity was not obtained, this data has not been reported.
Study:
NCT04998851
Study Brief:
Results Section:
NCT04998851